BANK OF AMERICA CORP /DE/

Bank

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 70858 CHARLOTTE, NC

Back to ARWR Full portfolio

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$92,905,911

+$26,164,585 QoQ

Shares Held

1,139,810

+7.1% QoQ

Ownership

0.807%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#21

of 497 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 76% Shared 0% None 24%

Common Shares in ARWR Over Time

Shares Held

Position Value (USD)

Derivatives in ARWR

reported options exposure · as of Jun 30, 2025

CallValue

$23,700

CallShares

1,500

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ARWR ranks #25 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,039,178	$1,509,650,884
2	REGN	Regeneron Pharmaceuticals, Inc.	1,291,053	$805,023,185
3	CYTK	Cytokinetics Inc	4,635,709	$394,916,048
4	ARGX	Argenx SE	400,234	$371,325,094
5	ALNY	Alnylam Pharmaceuticals, Inc.	994,476	$299,367,107
6	JAZZ	Jazz Pharmaceuticals plc	1,136,091	$273,763,844
7	TVTX	Travere Therapeutics, Inc.	4,568,341	$259,527,450
8	RPRX	Royalty Pharma plc	4,149,422	$232,658,090

All Filings in ARWR

Export CSV

32 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$92,905,911	1,139,810	+7.1%	Shares	Defined	2026-08-14
2026-03-31	$66,741,326	1,064,455	+71.1%	Shares	Defined	2026-05-18
2025-12-31	$41,296,502	622,029	-18.2%	Shares	Defined	2026-02-17
2025-09-30	$26,236,090	760,687	+21.8%	Shares	Defined	2026-02-03
2025-06-30	$9,867,035	624,496	-21.8%	Shares	Defined	2025-08-14
2025-06-30	$23,700	1,500	0.0%	Call	Defined	2025-08-14
2025-03-31	$10,169,064	798,200	+38.6%	Shares	Defined	2025-05-15
2025-03-31	$19,110	1,500	-21.1%	Call	Defined	2025-05-15
2024-12-31	$10,828,309	575,974	-0.5%	Shares	Defined	2025-02-14
2024-09-30	$11,210,580	578,760	+10.4%	Shares	Defined	2024-11-14
2024-06-30	$13,619,121	524,014	+13.7%	Shares	Defined	2024-08-14
2024-03-31	$13,178,019	460,770	-21.3%	Shares	Defined	2024-05-15
2023-12-31	$17,918,961	585,587	-47.0%	Shares	Defined	2024-02-14
2023-09-30	$29,695,967	1,105,172	+189.5%	Shares	Defined	2023-11-14
2023-06-30	$13,611,455	381,701	-19.8%	Shares	Defined	2023-08-14
2023-03-31	$12,084,479	475,767	-28.6%	Shares	Defined	2023-05-12
2022-12-31	$27,025,570	666,311	+36.8%	Shares	Defined	2023-02-10
2022-09-30	$16,096,371	487,031	-19.8%	Shares	Defined	2022-11-14
2022-06-30	$21,382,607	607,288	-26.6%	Shares	Defined	2022-08-12
2022-03-31	$38,030,598	826,932	+38.8%	Shares	Defined	2022-05-16
2021-12-31	$39,494,178	595,689	-3.2%	Shares	Defined	2022-02-08
2021-09-30	$38,436,400	615,672	+9.0%	Shares	Defined	2021-11-15
2021-06-30	$46,769,278	564,710	-6.0%	Shares	Defined	2021-09-13
2021-03-31	$39,843,420	600,866	+12.3%	Shares	Defined	2021-05-14
2020-12-31	$41,052,081	535,020	+2.9%	Shares	Defined	2021-02-10
2020-12-31	$145,787	1,900	0.0%	Call	Defined	2021-02-10
2020-09-30	$22,399,335	520,189	+3.5%	Shares	Defined	2020-11-13
2020-09-30	$81,814	1,900	0.0%	Call	Defined	2020-11-13
2020-06-30	$82,061	1,900	-67.8%	Call	Defined	2020-08-14
2020-06-30	$21,712,819	502,728	-6.2%	Shares	Defined	2020-08-14
2020-03-31	$15,414,100	535,770	—	Shares	Defined	2020-05-15
2020-03-31	$169,743	5,900	—	Call	Defined	2020-05-15
No filing history on record for this holder in this stock.